Adora2a inhibition via caffeine as a novel therapeutic target for cisplatin-induced chemobrain.

被引：0
|
作者：
Oliveros, Alfredo [1 ]
Corujo-Ramirez, Ana M. [1 ]
Yoo, Ki-Hyun [1 ]
Tang, Jason [1 ]
Brogren, Danielle [1 ]
Rashid, Mohammad A. [1 ]
Liu, Yuanhang [1 ]
Jang, Mi-Hyeon [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3115
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Adora2a inhibition as a novel therapeutic target for cisplatin chemobrain-induced cognitive dysfunction
    Oliveros, Alfredo
    Yoo, Ki-Hyun
    Tang, Jun
    Corujo, Ana M.
    Brogren, Danielle
    Liu, Yuanhang
    Jang, Mi-Hyeon
    CANCER RESEARCH, 2020, 80 (16)
  • [2] Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety
    Childs, Emma
    Hohoff, Christa
    Deckert, Juergen
    Xu, Ke
    Badner, Judith
    de Wit, Harriet
    NEUROPSYCHOPHARMACOLOGY, 2008, 33 (12) : 2791 - 2800
  • [3] Association between ADORA2A and DRD2 Polymorphisms and Caffeine-Induced Anxiety
    Emma Childs
    Christa Hohoff
    Jürgen Deckert
    Ke Xu
    Judith Badner
    Harriet de Wit
    Neuropsychopharmacology, 2008, 33 : 2791 - 2800
  • [4] Adora2A downregulation promotes caffeine neuroprotective effect against LPS-induced neuroinflammation in the hippocampus
    Sanna, Paula Lemes dos Santos
    Carvalho, Liebert Bernardes
    Afonso, Camila Cristina dos Santos
    de Carvalho, Kassia
    Aires, Rogerio
    Souza, Jennyffer
    Ferreira, Marcel Rodrigues
    Birbrair, Alexander
    Bernardi, Maria Martha
    Latini, Alexandra
    da Silva, Rodrigo A. Foganholi
    BRAIN RESEARCH, 2024, 1833
  • [5] Effects of ADORA2A gene variation and caffeine on prepulse inhibition: A multi-level risk model of anxiety
    Gajewska, Agnieszka
    Blumenthal, Terry D.
    Winter, Bernward
    Herrmann, Martin J.
    Conzelmann, Annette
    Muehlberger, Andreas
    Warrings, Bodo
    Jacob, Christian
    Arolt, Volker
    Reif, Andreas
    Zwanzger, Peter
    Pauli, Paul
    Deckert, Juergen
    Domschke, Katharina
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 40 : 115 - 121
  • [6] Supporting cells as a target of cisplatin-induced inner ear damage:: Therapeutic implications
    Ramírez-Camacho, R
    García-Berrocal, JR
    Buján, J
    Martín-Marero, A
    Trinidad, A
    LARYNGOSCOPE, 2004, 114 (03): : 533 - 537
  • [7] Adenosine A2A Receptor Gene (ADORA2A) Polymorphism: Exercise-Induced Pain, Eccentric Injury Responses And Caffeine Antagonism
    O'Connor, Pat
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2014, 46 (05): : 688 - 688
  • [8] Ezetimibe ameliorates cisplatin-induced nephrotoxicity: A novel therapeutic approach via modulating AMPK/Nrf2/TXNIP signaling
    Fathy, Nevine
    Farouk, Shaimaa
    Sayed, Rabab H.
    Fahim, Atef Tadros
    FASEB JOURNAL, 2024, 38 (01):
  • [9] Wedelolactone protects against cisplatin-induced nephrotoxicity in mice via inhibition of organic cation transporter 2
    Wang, Guangju
    Bi, Yajuan
    Xiong, Hui
    Bo, Tongwei
    Han, Lifeng
    Zhou, Lijun
    Zhang, Chunze
    Zhang, Youcai
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2021, 40 (12_SUPPL) : S447 - S459
  • [10] MDM2 inhibitor ameliorates cisplatin-induced nephropathy via NFκB signal inhibition
    Fujikura, Tomoyuki
    Yasuda, Hideo
    Iwakura, Takamasa
    Tsuji, Takayuki
    Anders, Hans-J
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2019, 7 (01):
12345